FEATURED PUBLICATIONS
Showing 19 - 28 of 97
Published date : 24 November 2022
Targeted therapy in cardiovascular diseases
Heart failure
Target therapy explores treatment with specific therapeutic drugs against pathogenic molecules or cells to ensure normal, healthy tissue is not affected. This allows the possibility of personalised, precise treatment. The most common targeted therapies include treatments such as protein or nucleic...
Reviewed by
Z. Beketova
Published in
Front Pharmacol 2021
Authors
Xu M & Song J
Published date : 24 November 2022
New factors in heart failure pathophysiology
Heart failure
Leukocyte-shed extracellular vesicles have been found to play effector roles in the pathophysiology of many different diseases. There are often high levels of leukocyte-shed extracellular vesicles found in inflamed tissues; this indicates immunity cell activation. Within this study, the link between...
Reviewed by
Z. Beketova
Published in
Front Cardiovasc Med 2022
Authors
Vilella-Figuerola A, Padró T, Roig E, et al.
Published date : 21 November 2022
INOCA: coronary microvascular disease responsible for perfusion abnormality?
Heart failure
The question was posed of whether myocardial perfusion imaging can predict the outcomes of patients with angina and ischemia with no obstructive coronary artery disease (INOCA). It was found that in INOCA patients, perfusion abnormalities were seen, which may be due...
Reviewed by
Z. Beketova
Published in
J Nucl Cardiol 2021
Authors
Sharir T & Brodkin B
Published date : 21 November 2022
ISCHEMIA trial follow-up: a review
Heart failure
The ISCHEMIA trial compared two strategies for patients with chronic coronary disease and moderate to severe ischemia: conservative management versus invasive management. However, no major differences were discovered after a follow-up of around 3.2 years. After 5.7 years, there was seen...
Reviewed by
Z. Beketova
Published in
Circulation 2022
Authors
Hochman J, Anthopolos R, Reynolds H, et al.
Published date : 15 November 2022
Endothelial dysfunction pose high risk of mayor CV events
Heart failure
Endothelial dysfunction has been noticed to be linked to cardiovascular events such as myocardial infarction and unstable angina, especially for patients with INOCA (ischaemia with no obstructive coronary artery disease). Endothelial dysfunction occurs when there is a limited availability of nitric...
Reviewed by
Z. Beketova
Published in
Int J Cardiol 2022
Authors
Grigorian-Shamagian L, Oteo JF, Gutiérrez-Barrios A, et al.
Published date : 15 November 2022
Impact of chronic HF on a person’s social dimension
Heart failure
Chronic heart failure is a very serious, disabling condition which brings around significant impacts. One of the main issues to note is the effect of chronic heart failure on the patient’s social life. This condition can lead to a decreased social...
Reviewed by
Z. Beketova
Published in
Health Soc Care Community 2022
Authors
Olano-Lizarraga M, Wallström S, Martín-Martín J, et al.
Published date : 10 November 2022
Qol after coronary artery bypass grafts in ischemic patients
Heart failure
A coronary artery bypass graft is a surgical procedure used in patients with coronary artery disease. Its goal is to relieve symptoms of angina, slow the progression of ischemic heart disease, and, in turn, increase quality of life and life expectancy....
Reviewed by
Z. Beketova
Published in
Atherosclerosis 2022
Authors
Borkhalenko Y, Yepanchintseva O, Todurov B, et al.
Published date : 10 November 2022
Diabetes and chronic coronary syndromes
Heart failure
The prevalence of diabetes is increasing across the globe, with an estimated 8.5% of adults globally suffering from this condition. However, there is little data discussing the relationship between diabetes mellitus and chronic coronary syndromes. There are significant differences in the...
Reviewed by
Z. Beketova
Published in
Eur J Prev Cardiol 2022
Authors
Mak KH, Vidal-Petiot E, Young R, et al.
Published date : 7 November 2022
Lessons Learned from the ISCHEMIA Trial
Heart failure
A recent trial by the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) addressed the idea of treating ischemia with invasive approaches to improve outcomes. They investigated whether this would prove more beneficial than non-invasive approaches, such...
Reviewed by
Z. Beketova
Published in
Annu Rev Med 2022
Authors
Boden WE & Stone PH
Published date : 7 November 2022
Current therapies for hypertrophic cardiomyopathy
Heart failure
Hypertrophic cardiomyopathy is the most common inherited heart diseases. Yet, there is currently no specific course of management or treatment for patients suffering with hypertrophic cardiomyopathy which modifies disease expression. This review synthesised current therapies, finding that invasive septal reductions increase...
Reviewed by
Z. Beketova
Published in
ESC Heart Fail 2022
Authors
Bayonas-Ruiz A, Muñoz-Franco FM, Sabater-Molina M, et al.